TLV monitors and analyses pharmaceutical prices, in Sweden and abroad. The international price comparison report is part of TLV’s assignment to monitor developments in the Swedish pharmaceutical market from an international perspective.
The latest report is the fourth report of its kind. Previous reports published in 2014 and 2015 are only available in Swedish. The reports for 2016 and 2017 are available in Swedish and English.
The analysis is based on national list prices at AIP level (pharmacy purchase price).
The analysis compares the price of medicine used in Swedish outpatient care to that of 19 other European countries: Austria, Belgium, the Czech Republic, Denmark, Finland, France, Germany, Great Britain, Greece, Hungary, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Switzerland, Slovakia, and Spain.
Pharmaceuticals have been divided into segments based on the prerequisite for competition in Sweden; pharmaceuticals not exposed to competition and those exposed to competition, which includes all pharmaceuticals included as substitutes for the ‘product-of-the-month’ in March 2017. In terms of volume, the two segments constitute approximately half of the market each. In terms om value, the segment pharmaceuticals not exposed to competition is significantly greater. Pharmaceutical data has been grouped by substance, dosage form and strength.